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Latent TBAbstract There is increased need for alternative biomarkers in diagnosis, prognosis and follow up
of patients with pulmonary tuberculosis and for differentiation between active and latent tubercu-
losis.
The aim of this work is to evaluate the efﬁcacy of inducible protein-10 (IP-10) as a biomarker in
the diagnosis of pulmonary tuberculosis as well as to elucidate its ability in distinguishing between
active and latent tuberculosis.
This study was carried out on 20 apparently healthy subjects (group I), 20 active pulmonary
tuberculosis (TB) patients (group II) and 20 latent TB patients (group III). They were matched
in age and sex. Group II were sub-classiﬁed into three subgroups according to the radiological
extent of the pulmonary lesion into: (Minimal, moderately advanced and far advanced lesions).
Blood samples were obtained and the determination of serum IP-10 levels by enzyme linked
immunosorbent assay methods were done (Sandwich) ELISA.
Tuberculin skin test (TST) was signiﬁcantly higher in group II and III compared to group I and it
was signiﬁcantly higher in group II compared to group III.
Serum IP-10 level was signiﬁcantly higher in group II and III as compared with group I and
higher in group II compared to group III, and it was also, signiﬁcantly higher in far advanced
lesions and moderately advanced lesions than minimal lesions.
Signiﬁcant positive correlations were found between serum IP-10 level and both TST and blood
lymphocyte%.
IP-10 showed sensitivity 88.9%, speciﬁcity 100% and accuracy 95.5% with positive predictive
value 100% and negative predictive value – 75% in diagnosis of active pulmonary and latent tuber-
culosis.
It was concluded that IP = 10 could be used as a diagnostic biomarker in the diagnosis of active
pulmonary and latent tuberculosis and it correlates well with disease severity.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).rculosis.
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Despite the global effort to reduce the burden of tuberculosis
(TB), TB is the highest infectious cause of mortality and mor-
bidity worldwide, with 1.7 million deaths and 9.4 million inci-
dent cases in 2009 alone. Efforts to reduce the TB burden are
linked to the development of rapid diagnostic tests for infec-
tion with Mycobacterium tuberculosis. The interferon-g (IFN-
g) release assay (IGRA), recently developed immunodiagnostic
test for TB, is available [1].
Compared with the tuberculin skin test (TST), the IGRA is
less inﬂuenced by the bacilli Calmette–Gue´rin (BCG) vaccine
and environmental mycobacterial exposure [2]. However, its
sensitivity is suboptimal in immunocompromised patients,
and its ability to discriminate between active TB and latent
TB infection (LTBI) is questionable [3,4].
The sensitivity of the IGRA can be enhanced by using alter-
native or additional biomarkers. IP-10 is produced primarily
by monocytes/macrophages and has a role in trafﬁcking ofFigure 1 Mean value of Serum IP-10 concentration in pg/ml in
the three studied groups.
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Figure 2 Correlation between serum IP-10 andTh1 lymphocytes to inﬂamed foci through an interaction with
a CXC chemokine receptor. High levels of IP-10 were found in
the pleural effusion and lung tuberculosis granuloma. IP-10
expression following stimulation with M. tuberculosis-speciﬁc
antigens is reported to be a promising biomarker with high
sensitivity for the immune-diagnosis of TB infection [5,6] (see
Fig. 2).
In contrast to IFN-g, IP-10 expression in response to TB-
speciﬁc antigen was not inﬂuenced by the ability to respond
to mitogens or by the CD4 cell number in HIV-infected
patients [7]. However, there have been discordant results
regarding whether IP-10 can distinguish between active TB
and LTBI. Plasma levels of IP-10 were higher in active TB
than in LTBI and showed a reduction at the end of M. tuber-
culosis treatment. In addition, baseline plasma IP-10 and CFP-
10-stimulated IP-10 levels were signiﬁcantly higher in active
TB than in LTBI in patients with rheumatoid arthritis [8].
Conversely, TB-speciﬁc antigen-stimulated IP-10 could not
distinguish between active TB and LTBI in children diagnosed
by IGRA [9].
Subjects and methods
This study had been carried out on 60 subjects admitted in the
El-Mahala Chest Hospital, and attending the outpatient clinic
of the Chest Department of Tanta University Hospitals, the
duration of the study was 18 months. Subjects were classiﬁed
into three groups (see Table 1).
Group I: Included 20 healthy volunteers with negative
tuberculin test, they didn’t have any history of contact with
active pulmonary tuberculosis patients and they were free of
tuberculosis symptoms.
Group II: Included 20 active tuberculous patients with pos-
itive sputum examination for acid fast bacilli by Ziehl–Neelsen
stain and positive tuberculin test.
Group III: Included 20 latent tuberculous patients with a
history of contact with active pulmonary tuberculosis cases1*
up II
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blood lymphocytes % in the studied groups.
Table 1 Laboratory data of the three studied groups.
Group I Group II Group III
Hemoglobin
(gm %)
12.5 ± 1.22 9.15 ± 1.34* 11.7 ± 1.22
Total leukocytic
count
(TLC  103).
10.95 ± 0.945 10.300 ± 1.081 10.800 ± 1.005
Lymphocytes % 26.0 ± 7.53 64.5 ± 10.5* 28.5 ± 8.13
ESR mm 4.9 ± 1.74 69.5 ± 21.39* 6.8 ± 2.0
* Signiﬁcance compared to group I & II.
Table 3 Statistical comparison of serum IP-10 and severity of
the disease according to X-ray ﬁnding in group II.
X-ray ﬁnding
(Group II)
Serum inducible
protein-10 (pg/ml)
ANOVA
Range Mean
± SD
F P-value
Minimal 135–500 285.385
± 95.775
28.402 <0.001*
Moderately
advanced
600–1000 783.333
± 202.073
Far advanced 600–1500 1062.500
± 381.608
Tukey’s test
Minimal and
moderately
advanced
Minimal and
far advanced
Moderately advanced & far
advanced
0.002* <0.001* 0.169
* Signiﬁcance.
IP-10 in Pulmonary TB 221for more than one month, normal Chest X-ray, negative spu-
tum examination for acid fast bacilli by Ziehl–Neelsen stain
and positive tuberculin test.
The protocol of the study was approved by the ethics com-
mittee in the Tanta Faculty of Medicine and written informed
consent was taken from all subjects in the study (see Table 3).
Exclusion criteria:
 Patients with other co-morbid pulmonary diseases, e.g.
COPD, bronchial asthma, pneumonia and respiratory
failure.
 Patients with other medical co-morbid diseases, e.g. D.M.,
heart failure and renal failure.
 Patients with autoimmune disorders including systemic
lupus erythematosus, primary biliary cirrhosis and atopic
dermatitis.
 Patients with HIV infection, lymphoma, leukemia, patients
who had received anti tuberculous therapy for more than
2 weeks and patients who received immunosuppressive ther-
apy within 3 months of enrollment.
All subjects in this study were subjected to the following:
1. Thorough history taking and complete physical
examination.
2. Calculation of body mass index.
3. Routine laboratory investigations including complete blood
picture, ESR, fasting and postprandial blood glucose levels,
blood urea, serum creatinine levels.
4. Sputum examination for acid fast bacilli on 3 successive
days by Ziehl–Neelsen staining.
5. Plain X-ray and CT for some cases for the exclusion of
other pulmonary co-morbidity and conﬁrming diagnosis
& extent of the lesions.Table 2 Mean value ± SD and statistical comparison o
TST diameter G I
Range 2.0–4.0 mm
Mean ± SD 2.75 ± 0.638 mm
F test 266.689
P value 0.001*
Scheﬀe test
G I and G II G I and G III
0.001* 0.001*
* Signiﬁcance.6. Tuberculin skin test.
7. Blood samples withdrawn and examined for inducible
protein-10 using the ELISA technique (OmniKineTM
Human IP-10 ELISA Kit).
Results
This study had been carried out on 60 subjects admitted in El-
Mahala Chest Hospital, and attending the outpatient clinic of
the Chest Department of Tanta University Hospitals, the
study extended from June 2013 to September 2014 (see
Table 4).
The subjects were classiﬁed into three groups:
Group I: Included 20 healthy volunteers. They were 8 males
and 12 females, their ages ranged from (23 to 60) years with
a mean value of 42.35 ± 11.06 years.
Group II: Included 20 active tuberculous patients. They
were 15 males and 5 females, their ages ranged from (14
to 73) years with a mean value of 44.0 ± 15.94 years.
Group II was reclassiﬁed into three subgroups according
to the extent of the lesion in the CXR.
 Minimal lesion: included 13 patients (10 males and 3
females).f TST diameter in the three studied groups.
G II G III
11.0–16.0 mm 11.0–13.0 mm
12.25 ± 1.74 mm 11.9 ± 0.788 mm
G II and G III
0.639
Table 4 Sensitivity and speciﬁcity of IP-10 in the diagnosis of
TB.
ROC curve
Cutoﬀ Sens. Spec. PPV NPV Accuracy
>125* 88.9 100.0 100.0 75.0 95.5%
* Specify the IP-10 cutoff value in TB.
222 F.A. El-emiry et al. Moderately advanced lesion: included 3 patients (2 females
and one male).
 Far advanced lesion: included 4 males.
Group III: Included 20 latent tuberculous patients. They
were 9 males and 11 females, their ages ranged from 21 to
74 years with a mean value of 47.45 ± 14.17 years (see
Fig. 3).
The mean value ± SD of TST in the three studied groups
were (2.75 ± 0.638) mm in group I, (12.25 ± 1.74) mm in
group II and (11.9 ± 0.788) mm in group III. It was signiﬁ-
cantly higher in group II and group III as compared with
group I. No statistical signiﬁcant difference seen between
group II and III (Table 2).
Serum inducible protein-10 concentration in pg/ml in the three
studied groups in table (Fig. 1):
The mean values of serum IP-10 concentration in the three
studied groups were 72.87 ± 18.17 pg/ml in group I, 515.5
± 378.99 pg/ml in group II and 286.5 ± 135.10 pg/ml in
group III. One way analysis of variance showed a statistical
signiﬁcant difference (F= 18.123, p< 0.001). Pairwise multi-
ple comparisons (Scheffe test) showed that serum IP-10 was
signiﬁcantly higher in group II and group III compared to
group I and it was signiﬁcantly higher in group II compared
to group III (p< 0.05) (see Fig. 4).
Discussion
Tuberculosis (TB) is a major cause of death around the world,
with most of the 1.5 million deaths per year attributable to theserum IP-10
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Figure 3 Correlation between serum IP-10disease occurring in developing countries. One of the most
important and common complaints of tuberculous patients
which also affects the immune status is weight loss. Some
cytokines promote inﬂammation and are called proinﬂamma-
tory cytokines (tumor necrosis factor-Alfa (TNF-a), inter-
leukin (IL)-1, IL-6, and IL-8), whereas other cytokines
suppress the activity of proinﬂammatory cytokines and are
called anti-inﬂammatory cytokines (IL-4, IL-10, and IL-
13)(121). Proinﬂammatory cytokines are prime candidates as
causative agents of the metabolic changes that eventually
result in tuberculosis-associated weight loss. TNF-a has some
harmful effects, such as acute-phase pathophysiologic events
including fever and tissue necrosis. It also plays a protective
role against mycobacterial infection [10].
IP-10 is produced primarily by monocytes/macrophages
and has a role in chemo-attraction of Th1 lymphocytes to
inﬂamed foci through an interaction with a CXC chemokine
receptor. High levels of IP-10 were found in the pleural effu-
sion and lung tuberculosis granuloma of TB patients. Previous
studies have reported that IP-10 expression following stimula-
tion with M. tuberculosis-speciﬁc antigens is a promising bio-
marker with high sensitivity for the immunodiagnosis of TB
infection [11].
In this study, Hemoglobin level (gm%) was signiﬁcantly
lowered in group II as compared to group I and group III
and this was in accordance with Atomsa et al., [12] their study
showed that mean RBC counts, Hgb, MCV, MCH and
MCHC values were signiﬁcantly lower than the corresponding
control group for both males and females.
Other similar studies have reported lower hemoglobin levels
among TB patients. However, a study conducted on adult
patients diagnosed with TB at the Seoul National University
Hospital, Korea among 880 patients, anemia was identiﬁed
in 281 patients (31.9%) at the time of diagnosis which was
lower than the present study. It also showed that normocytic
normochromic anemia was the most common and identiﬁed
in 202 (71.9%) patients and followed by microcytic hypochro-
mic anemia 26 (9.1%). On the other hand, a study conducted
in India reported normocytic normochromic anemia as the
most common abnormality observed in all cases, groups and
subgroups. The variation might be due to the difference in160014001200100000
and TST diameter in the studied groups.
Figure 4 (a and b): Sensitivity and speciﬁcity of IP-10 in the diagnosis of TB.
IP-10 in Pulmonary TB 223the stage of the disease during diagnosis, geographic, nutrition
and other cultural differences that may directly or indirectly be
related to anemia [13].
In this study, total leukocytic counts were within the nor-
mal range in the three studied groups with no statistical signif-
icant difference. Blood Lymphocytes % was signiﬁcantly
higher in group II compared with group I and group III. This
was in accordance with Gambo´n-Deza et al., [14] their study
has shown peripheral blood lymphocytosis produced during
the initial weeks ofM. tuberculosis infection. SinceM. tubercu-
losis bacilli grow inside phagocytic vacuoles, the bacterial anti-
gens must be presented by class II major histocompatibility
complex molecules, and, therefore, the response must be con-
veyed by CD4 T cells. Other studies showed an increase in
the numbers of CD8 T lymphocytes in recent infections, while
these cells were also present in the pleural ﬂuids of the active
tuberculosis patients. These CD8 lymphocytes may correspond
to those directed against self-heat shock protein that may have
been produced during the infectious process.
Erythrocyte sedimentation rate was signiﬁcantly higher in
group II as compared with group I and group III. Previous
studies have documented an elevated ESR level in majority
of patients which decreased signiﬁcantly in those with sputumconversion. It was in accordance with the study done by Al-
Marri and Kirkpatrick [15] which found that children with
symptomatic tuberculosis had signiﬁcantly higher ESR values
than asymptomatic children with tuberculosis and likewise
children with positive culture for tuberculosis had signiﬁcantly
higher ESR values than children with negative tuberculosis
cultures. Nevertheless, there was a large range of individual
values with considerable overlap, making it difﬁcult to see
how individual patient values could be of any utility in either
diagnosing or excluding tuberculosis [16].
Inducible protein-10 (IP-10) level was signiﬁcantly higher in
tuberculous and latent groups as compared with the control
group and signiﬁcantly higher in active pulmonary tuberculo-
sis compared to latent tuberculosis. So, serum IP-10 can differ-
entiate between active, latent TB and normal cases.
Hong et al., [1] evaluated inducible protein 10 (IP-10) as a
diagnostic biomarker for speciﬁc tuberculosis (TB) infection
and evaluated the ability of IP-10 to distinguish between active
TB and latent TB infection (LTBI). Their study was carried
out on 46 patients with active pulmonary TB, 22 participants
with LTBI, and 32 non-TB controls were enrolled separately.
IP-10 was measured in serum and in supernatants from whole
blood stimulated with TB-speciﬁc antigens. The results showed
224 F.A. El-emiry et al.that TB antigen-dependent IP-10 secretion was signiﬁcantly
increased in the active TB patients and LTBI subjects com-
pared with controls, but did not differ signiﬁcantly between
the active TB patients and LTBI subjects. Serum IP-10 levels
were higher in active TB than in LTBI [1].
The present work was in accordance with Azab et al., [17].
Their study was investigating the utility of IP-10 in both blood
and bronchoalveolar lavage (BAL) in the diagnosis of TB
infection in clinically suspected patients. The study was carried
out on thirty patients with clinical and/or radiological suspi-
cion of pulmonary tuberculosis and negative sputum smear
for AFB with Z–N stain were included in the study. BAL
and blood samples were sent for the estimation of the level
of IP-10. The results showed that levels of IP-10 in both blood
and BAL were signiﬁcantly higher in TB patients.
Also the present study was in accordance with Syed
Ahamed Kabeer [18] his study carried out on 277 subjects
recruited during the study period. There were 100 healthy con-
trols and 177 PTB patients. Blood was unavailable for 2 PTB
patients. Tuberculin skin test results were unavailable for 6
healthy controls and 58 (32.8%) PTB patients. All the subjects
were negative for HIV infection and the demographic proﬁle
of those subjects is given. All the healthy controls were nega-
tive for sputum smear microscopy and sputum culture. In
PTB, sputum smear microscopy was positive in 151 (85.3%)
subjects and sputum culture was positive in 162 (91.5%) sub-
jects. All the sputum smear positive cases were positive for spu-
tum culture. Levels of IP-10 in unstimulated plasma ranged
from 0 to 6975 pg/ml (median 390 pg/ml) in healthy controls
and 0–5973 pg/ml (median 898 pg/ml) in PTB patients respec-
tively. TB speciﬁc antigens and mitogen stimulated signiﬁ-
cantly higher levels of IP-10 secretion in healthy controls as
well as TB patients. Levels of IFN-c were also signiﬁcantly
higher in TB antigens as well as mitogen stimulated samples
than unstimulated samples of healthy controls and PTB
subjects.
Jeong et al., [19] their study aimed to identify a parameter
that helped to discriminate active TB and LTBI. This study
was carried out on 33 active TB patients, 20 individuals with
LTBI, and 26 non-TB controls. The results showed that IP-
10 was more useful in discriminating active TB from LTBI
and it was not in accordance with our present study because
in their study other parameters like Quantiferon-TB gold,
IFN-c and TNF-a and others were used with IP-10 to discrim-
inate active TB and LTBI.
Other studies showed also elevated IP-10 level in pleural
effusions as in Dheda et al., [20] their study investigated the
comparative diagnostic utility of established (adenosine deam-
inase [ADA]), more recent (standardized nucleic-acid-
ampliﬁcation-test [NAAT]) and newer technologies (a stan-
dardized LAM mycobacterial antigen-detection assay and
IP-10 levels) for the evaluation of pleural effusions in 78 con-
secutively recruited South African tuberculosis suspects. All
consenting participants underwent pleural biopsy unless
contra-indicated or refused. The reference standard comprised
culture positivity for M. tuberculosis or histology suggestive of
tuberculosis. Of the 74 evaluable subjects 48, 7 and 19 had def-
inite, probable and non-TB, respectively. IP-10 levels were sig-
niﬁcantly higher in TB vs non-TB participants.In the present study, there was a positive correlation
between serum IP-10 and severity of TB in group II and it
was in accordance with Tonby et al., [21] their study analyzed
IP-10 levels in plasma directly and extracted from dry plasma
spot (DPS) in parallel by ELISA from 34 clinically well char-
acterized patients with TB disease before and throughout
24 weeks of effective anti-TB chemotherapy. they detected a
signiﬁcant decline of IP-10 levels in both plasma and DPS
already after two weeks of therapy with good correlation
between the tests. So IP-10 level decreases with a decrease in
the severity of TB(132).
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